Saltar al contenido
MilliporeSigma
  • Macrophage migration inhibitory factor promotes expression of GLUT4 glucose transporter through MEF2 and Zac1 in cardiomyocytes.

Macrophage migration inhibitory factor promotes expression of GLUT4 glucose transporter through MEF2 and Zac1 in cardiomyocytes.

Metabolism: clinical and experimental (2015-10-13)
Yeyou Liang, Weiwei Yuan, Wensi Zhu, Jiening Zhu, Qiuxiong Lin, Xiao Zou, Chunyu Deng, Yongheng Fu, Xilong Zheng, Min Yang, Shulin Wu, Xiyong Yu, Zhixin Shan
RESUMEN

Evidence shows that both macrophage migration inhibitory factor (MIF) and GLUT4 glucose transporter are involved in diabetic cardiomyopathy (DCM), but it remains largely unknown whether and how MIF regulates GLUT4 expression in cardiomyocytes. The present study aims to investigate the mechanism underlying the modulation of GLUT4 by MIF in cardiomyocytes. Activations of AKT and AMPK signaling, and expressions of MIF, GLUT4 and the candidate GLUT4 regulation associated transcription factors in the diabetic mouse myocardium were determined. The screened transcription factors mediating MIF-promoted GLUT4 expression were verified by RNA interference (RNAi) and electrophoretic mobility shift assay (EMSA), respectively. MIF was increased, but GLUT4 was decreased in the diabetic mouse myocardium. MIF could enhance glucose uptake and up-regulate GLUT4 expression in NMVCs. Expressions of transcription factor MEF2A, -2C, -2D and Zac1 were significantly up-regulated in MIF-treated neonatal mouse ventricular cardiomyocytes (NMVCs), and markedly reduced in the diabetic myocardium. Knockdown of MEF2A, -2C, -2D and Zac1 could significantly inhibit glucose uptake and GLUT4 expression in cardiomyocytes. Moreover, EMSA results revealed that transcriptional activities of MEF2 and Zac1 were significantly increased in MIF-treated NMVCs. AMPK signaling was activated in MIF-stimulated NMVCs, and AMPK activator AICAR could enhance MEF2A, -2C, -2D, Zac1 and GLUT4 expression. Additionally, MIF effects were inhibited by an AMPK inhibitor compound C and siRNA targeting MIF receptor CD74, suggesting the involvement of CD74-dependent AMPK activation. Transcription factor MEF2 and Zac1 mediate MIF-induced GLUT4 expression through CD74-dependent AMPK activation in cardiomyocytes.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
D-(+)-Glucosa, ≥99.5% (GC)
Sigma-Aldrich
D-(+)-Glucosa, powder, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥99.5%
Sigma-Aldrich
Dextrosa, 97.5-102.0% anhydrous basis, meets EP, BP, JP, USP testing specifications
Sigma-Aldrich
D-(+)-Glucosa, ≥99.5% (GC), BioXtra
Sigma-Aldrich
D-(+)-Glucosa, BioUltra, anhydrous, ≥99.5% (sum of enantiomers, HPLC)
Sigma-Aldrich
Dorsomorphin, ≥98% (HPLC)
Sigma-Aldrich
AICAR, ≥98% (HPLC), powder
Supelco
D-(+)-Glucosa, analytical standard
Sigma-Aldrich
D-(+)-Glucosa, suitable for mouse embryo cell culture, ≥99.5% (GC)
Sigma-Aldrich
1,1,2,2-Tetrabromoethane, 98%
Sigma-Aldrich
D-(+)-Glucosa, ACS reagent
Sigma-Aldrich
D-(+)-Glucosa, Hybri-Max, powder, BioReagent, suitable for hybridoma
Sigma-Aldrich
Tris(tert-butoxy)silanol, 99.999%
Sigma-Aldrich
D-(+)-Glucosa, 99.9 atom % 16O, 99.9 atom % 12C
Sigma-Aldrich
1,1,2,2-Tetrabromoethane, SAJ first grade, ≥98.0%
Sigma-Aldrich
MISSION® esiRNA, targeting human MIF
Sigma-Aldrich
MISSION® esiRNA, targeting human PLAGL1
Sigma-Aldrich
MISSION® esiRNA, targeting human CD74
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Mef2d
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Mif
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Mef2a
Sigma-Aldrich
MISSION® esiRNA, targeting human MEF2C
Sigma-Aldrich
MISSION® esiRNA, targeting human MEF2D
Sigma-Aldrich
MISSION® esiRNA, targeting human MEF2A
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Cd74